These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30180918)

  • 21. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
    Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.
    McClure MM; Graff F; Triebwasser J; Perez-Rodriguez M; Rosell DR; Koenigsberg H; Hazlett EA; Siever LJ; Harvey PD; New AS
    Am J Psychiatry; 2019 Apr; 176(4):307-314. PubMed ID: 30654644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing assertive community treatment with cognitive behavioral social skills training for schizophrenia: study protocol for a randomized controlled trial.
    Granholm E; Holden JL; Sommerfeld D; Rufener C; Perivoliotis D; Mueser K; Aarons GA
    Trials; 2015 Sep; 16():438. PubMed ID: 26424639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study.
    Roberts DL; Penn DL
    Psychiatry Res; 2009 Apr; 166(2-3):141-7. PubMed ID: 19272654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effects of Metacognition-Oriented Social Skills Training on Psychosocial Outcome in Schizophrenia-Spectrum Disorders: A Randomized Controlled Trial.
    Inchausti F; García-Poveda NV; Ballesteros-Prados A; Ortuño-Sierra J; Sánchez-Reales S; Prado-Abril J; Aldaz-Armendáriz JA; Mole J; Dimaggio G; Ottavi P; Fonseca-Pedrero E
    Schizophr Bull; 2018 Oct; 44(6):1235-1244. PubMed ID: 29267940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
    Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.
    Woolley JD; Chuang B; Fussell C; Scherer S; Biagianti B; Fulford D; Mathalon DH; Vinogradov S
    Psychol Med; 2017 May; 47(7):1311-1322. PubMed ID: 28091349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial.
    De Coster L; Lin L; Mathalon DH; Woolley JD
    Neuropsychopharmacology; 2019 Oct; 44(11):1925-1931. PubMed ID: 31103018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quasi-randomized feasibility pilot study of specific treatments to improve emotion recognition and mental-state reasoning impairments in schizophrenia.
    Marsh PJ; Polito V; Singh S; Coltheart M; Langdon R; Harris AW
    BMC Psychiatry; 2016 Oct; 16(1):360. PubMed ID: 27776504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    J Psychiatr Brain Sci; 2019; 4(1):. PubMed ID: 31037274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social Cognition and Interaction Training (SCIT) versus Training in Affect Recognition (TAR) in patients with schizophrenia: A randomized controlled trial.
    Lahera G; Reboreda A; Vallespí A; Vidal C; López V; Aznar A; Fernández P; Escolar M; Martínez-Alés G; Rodriguez-Jimenez R; Halverson T; Frommann N; Wölwer W; Penn DL
    J Psychiatr Res; 2021 Oct; 142():101-109. PubMed ID: 34332374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in Negative Symptoms and Functioning in Cognitive-Behavioral Social Skills Training for Schizophrenia: Mediation by Defeatist Performance Attitudes and Asocial Beliefs.
    Granholm E; Holden J; Worley M
    Schizophr Bull; 2018 Apr; 44(3):653-661. PubMed ID: 29036391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
    Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
    Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social cognitive interventions for people with schizophrenia: A systematic review.
    Tan BL; Lee SA; Lee J
    Asian J Psychiatr; 2018 Jun; 35():115-131. PubMed ID: 27670776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized waitlist control community study of Social Cognition and Interaction Training for people with schizophrenia.
    Gordon A; Davis PJ; Patterson S; Pepping CA; Scott JG; Salter K; Connell M
    Br J Clin Psychol; 2018 Mar; 57(1):116-130. PubMed ID: 28990190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
    Andari E; Massa NM; Fargotstein MD; Taylor NB; Halverson DM; Owens AV; Currin DL; Bhattacharya A; Gitman D; Cuthbert BC; Young LJ; Duncan EJ
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):103-113. PubMed ID: 33587397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
    Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
    Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.
    Bowie CR; McGurk SR; Mausbach B; Patterson TL; Harvey PD
    Am J Psychiatry; 2012 Jul; 169(7):710-8. PubMed ID: 22581070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.